Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 524Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 11Vimpat

PharmaCompass

01

Brand Name : Vimpat

Lacosamide

arrow
BMWS24
Not Confirmed

Brand Name : Vimpat

arrow
BMWS24
Not Confirmed

Lacosamide

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 1,441

2018 Revenue in Millions : 1,197

Growth (%) : 20

blank

02

Brand Name : Vimpat

Lacosamide

arrow
BMWS24
Not Confirmed

Brand Name : Vimpat

arrow
BMWS24
Not Confirmed

Lacosamide

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 128

2019 Revenue in Millions : 95

Growth (%) : 35

blank

03

Brand Name : Vimpat

Lacosamide

arrow
BMWS24
Not Confirmed

Brand Name : Vimpat

arrow
BMWS24
Not Confirmed

Lacosamide

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2020 Revenue in Millions : 1,755

2019 Revenue in Millions : 1,599

Growth (%) : 10

blank

04

Brand Name : Vimpat

Lacosamide

arrow
BMWS24
Not Confirmed

05

Brand Name : Vimpat

Lacosamide

arrow
BMWS24
Not Confirmed

Brand Name : Vimpat

arrow
BMWS24
Not Confirmed

Lacosamide

Main Therapeutic Indication : Neurology

Currency : USD

2021 Revenue in Millions : 1,705

2020 Revenue in Millions : 1,755

Growth (%) : 7

blank

06

Brand Name : Vimpat

Lacosamide

arrow
BMWS24
Not Confirmed

07

Brand Name : Vimpat

Lacosamide

arrow
BMWS24
Not Confirmed

08

Brand Name : Vimpat

Lacosamide

arrow
BMWS24
Not Confirmed

Brand Name : Vimpat

arrow
BMWS24
Not Confirmed

Lacosamide

Main Therapeutic Indication : Neurology

Currency : USD

2022 Revenue in Millions : 1,198

2021 Revenue in Millions : 1,705

Growth (%) : -30

blank

09

Brand Name : Vimpat

Lacosamide

arrow
BMWS24
Not Confirmed

Brand Name : Vimpat

arrow
BMWS24
Not Confirmed

Lacosamide

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 425

2022 Revenue in Millions : 1,197

Growth (%) : 185

blank

10

Brand Name : Vimpat

Lacosamide

arrow
BMWS24
Not Confirmed

Brand Name : Vimpat

arrow
BMWS24
Not Confirmed

Lacosamide

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 96

2018 Revenue in Millions : 69

Growth (%) : 39

blank